Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2023 Earnings Call Transcript

Anna Marie Wagner: Good afternoon. I'm Anna Marie Wagner, SVP of Corporate Development at Ginkgo Bioworks. I'm joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO.

Related Keywords

Ukraine ,Perth ,Western Australia ,Australia ,Alexandria ,Al Iskandariyah ,Egypt ,Jason Kelly ,Kendall Square ,Anna Marie ,Marcus Schindler ,Mark Dmytruk ,Novo Nordisk ,Nicholas Ohler ,Anna Marie Wagner ,Protein Expression Service ,Genentech Inc ,Ginkgo Cell Therapy Services ,Enzyme Optimization Service ,Syngenta ,Ginkgo Bioworks Holdings Inc ,Corporate Development At Ginkgo Bioworks ,Exchange Commission ,Ginkgo Microbe Services ,Enzyme Services ,Therapeutic Services ,Ginkgo Enzyme Discovery Service ,Boehringer Ingelheim ,Ginkgo Enzyme Services ,Youtube ,Ginkgo Bioworks Holdings ,Call Transcript May ,Bioworks Holdings ,Marie Wagner ,Corporate Development ,Thanks Anna ,Ginkgo Ferment ,Cell Engineering ,Brian Vandahl ,Radiant Genomics ,Warp Drive Bio ,Chief Technology Officer ,Bob Reiter ,Crop Science ,Ginkgo Enzyme ,